Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:5:p19
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 5 (pt 19/22)
Character Range: 301297–304330

each containing 120 mg or less of sarolaner per dosage unit.
SEDAXANE.
SELAMECTIN except in preparations containing 12% or less of selamectin.
SETHOXYDIM.
SIDURON.
SILICOFLUORIDES in preparations containing 3% or less of fluoride ion except:
 (a) barium silicofluoride when separately specified in this Schedule; or
 (b) in preparations containing 15 mg/kg or less of fluoride ion.
SINBIOALLETHRIN in preparations containing 10% or less of sinbioallethrin except in preparations containing 1% or less of sinbioallethrin.
SODIUM BROMIDE except when included in Schedule 4.
SODIUM CHLORATE except in preparations containing 10% or less of sodium chlorate.
SODIUM DIACETATE except in preparations containing 60% or less of sodium diacetate.
SODIUM DODECYLBENZENE SULFONATE except in preparations containing 30% or less of sodium dodecylbenzene sulfonate.
SODIUM HYDROGEN SULFATE except in preparations containing 10% or less of sodium hydrogen sulfate.
SODIUM HYDROSULFITE when packed for domestic use except in preparations containing 10% or less of sodium hydrosulfite.
SODIUM HYDROXIDE (excluding its salts and derivatives) in preparations containing 5% or less of sodium hydroxide being:
 (a) solid preparations, tHE pH of which in a 10 g/L aqueous solution is more than 11.5; or
 (b) liquid or semi‑solid preparations, tHE pH of which is more than 11.5 except in food additive preparations for domestic use.
SODIUM LAURETH‑6 CARBOXYLATE except in preparations containing 1% or less of sodium laureth‑6 carboxylate.
SODIUM METABISULPHITE when packed for domestic use except in preparations containing 10% or less of sodium metabisulphite.
SODIUM NITRITE in preparations containing 1% or less of sodium nitrite except:
 (a) in preparations containing 0.5% or less of sodium nitrite; or
 (b) when present as an excipient in preparations for therapeutic use; or
 (c) in aerosols.
SODIUM PERCARBONATE (CAS No. 15630‑89‑4) in preparations containing 35% or less of sodium percarbonate except in preparations containing 15% or less of sodium percarbonate.
SODIUM POLYSTYRENE SULPHONATE in preparations for cosmetic use except in preparations containing 10% or less of sodium polystyrene sulphonate.
SODIUM STANNATE except in preparations for cosmetic use containing 1% or less of sodium stannate.
SODIUM SULFIDE in preparations for metal treatment in containers each containing 50 g or less of sodium sulfide.
SPINETORAM.
SPINOSAD except in aqueous suspensions containing 25% or less of spinosad.
SPIROMESIFEN for agricultural use.
STAR ANISE OIL except:
 (a) in medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert and compliant with the requirements of the required advisory statements for medicine labels; or
 (b) in preparations other than medicines for human therapeutic use, when packed in containers having a nominal capacity of 50 mL or less fitted with a restricted flow insert, and labelled with the warning:

           KEEP OUT OF REACH